Sanofi's $20 Billion US Investment Sparks Criticism from French Finance Minister
2025-05-15

Reuters
French drugmaker Sanofi's decision to invest a substantial $20 billion in the United States through 2030 has drawn criticism from France's Finance Minister. The move, announced recently, involves significant capital expenditure across various projec ...Read more